Home Newsfeeds DoubleDown Interactive Q2 Sales $80.60M Miss $83.51M Estimate

DoubleDown Interactive Q2 Sales $80.60M Miss $83.51M Estimate

DoubleDown Interactive (NASDAQ:DDI) reported quarterly sales of $80.60 million which missed the analyst consensus estimate of $83.51 million by 3.48 percent.

byBenzinga Newsdesk

August 9, 2022

1 minute read

DoubleDown Interactive (NASDAQ:DDI) reported quarterly sales of $80.60 million which missed the analyst consensus estimate of $83.51 million by 3.48 percent.

Movers
News

What’s Going On With Matinas Biopharma Holdings Stock?

By Erica Kollmann

October 11, 1:44 PM

Matinas Biopharma Holdings, Inc. (AMEX:MTNB) shares are trading higher on Wednesday after the company announced complete clinical resolution of a patient's recurrent hemorrhagic cystitis following treat

MTNB

Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn’t Over Yet

By Shanthi Rexaline

April 26, 6:48 AM

Tech earnings could come to the market’s rescue as traders remain jittery about the outcome of key inflation data due on Friday.

ABBV

News

Johnson & Johnson Unit Janssen Announced New STELARA Long-Term Data Support Its Established Safety Profile In Inflammatory Bowel Disease And Durable Efficacy In Ulcerative Colitis

By Charles Gross

March 4, 10:58 AM

he Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab) through five years in adults with moderately to severely active Crohn's disease (CD) and four years in adults with moderately to severely active ulcerative colitis (UC), as well as final four-year clinical and endoscopic outcomes from the UNIFI long-term extensi

JNJ